Artemis Investment Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-13,214
Closed -$844K 235
2023
Q1
$844K Sell
13,214
-1,760
-12% -$115K 0.01% 199
2022
Q4
$729K Sell
14,974
-1,265
-8% -$79.3K 0.01% 211
2022
Q3
$1.15M Sell
16,239
-15,118
-48% -$1.29M 0.01% 207
2022
Q2
$2.23M Buy
31,357
+7,206
+30% +$464K 0.02% 210
2022
Q1
$1.93M Buy
24,151
+8,212
+52% +$612K 0.02% 241
2021
Q4
$1.45M Buy
15,939
+4,186
+36% +$449K 0.01% 254
2021
Q3
$1.51M Buy
11,753
+3,480
+42% +$487K 0.01% 266
2021
Q2
$1.26M Buy
+8,273
New +$1.09M 0.01% 268
2018
Q4
Sell
-191,230
Closed -$9.17M 293
2018
Q3
$9.17M Sell
191,230
-68,205
-26% -$2.79M 0.1% 203
2018
Q2
$8.04M Buy
+259,435
New +$6.07M 0.11% 174

Other funds holding STAA

Artemis Investment Management's STAA Position: Q2 2023 in Review

Artemis Investment Management sold out of STAAR Surgical (STAA) in Q2 2023, closing a stake of 13,214 shares — an estimated $844K sold.

Artemis Investment Management first reported a position in STAA in Q2 2018 and held it in 10 quarters. The position peaked at $9.17M in Q3 2018. 245 funds tracked by Wall St. Rank hold STAA as of Q2 2023.

  • Artemis Investment Management reported no remaining STAAR Surgical position as of Q2 2023 after selling out during the quarter.
  • Artemis Investment Management sold 13,214 STAAR Surgical shares in Q2 2023, an estimated $844K.
  • Artemis Investment Management first reported a position in STAAR Surgical in Q2 2018 and held it in 10 quarters.
  • Artemis Investment Management's STAAR Surgical position peaked at $9.17M in Q3 2018.
  • 245 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2023.

Based on Artemis Investment Management's 13F filing for Q2 2023, filed 19 Jul 2023.